Form 4: Protagonist Therapeutics CEO Gifts Shares to Grandchildren, SEC Filing Reveals

Protagonist Therapeutics, Inc. CEO and President Dinesh V. Patel, Ph.D., reported gifting a total of 1,355 shares of common stock to his grandchildren in mid-June 2025, as disclosed in a recent SEC Form 4 filing.

Summary

• Dinesh V. Patel, Ph.D., the President and CEO, Director, and 10% Owner of Protagonist Therapeutics, Inc. (PTGX), reported changes in his beneficial ownership.
• On June 13, 2025, Dr. Patel disposed of 670 shares of Common Stock through a bona fide gift.
• On June 16, 2025, Dr. Patel disposed of an additional 685 shares of Common Stock, also via a bona fide gift.
• Both transactions were reported with a price of $0 per share, consistent with gifts.
• Following these transactions, Dr. Patel's direct beneficial ownership of Common Stock stands at 562,905 shares.
• The gifts were made to his grandchildren.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A gift of shares is a personal transaction and does not typically reflect positively or negatively on the company's operational performance or future prospects. It's a routine disclosure for insider activity.

Positives

• The transactions represent bona fide gifts, indicating a personal financial planning decision rather than a sale for liquidity or a lack of confidence in the company.

Negatives

• The transactions result in a slight reduction in the direct beneficial ownership of common stock by a key executive, though the amount is minor relative to total holdings.

Future Outlook

This document, an SEC Form 4, reports insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This SEC Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies. It reflects a personal financial decision by an executive and does not inherently indicate broader industry trends or competitive positioning within the biotechnology or pharmaceutical sector.

Related Party Transactions

• The transactions involve bona fide gifts of securities from the Reporting Person (Dinesh V. Patel) to his grandchildren, which are considered related party transactions.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but not a sale, so minimal direct impact on shareholder confidence or share price. It's a routine disclosure.

Key Dates

Keywords

Protagonist Therapeutics, PTGX, Dinesh V. Patel, SEC Form 4, Insider Transaction, Stock Gift, Beneficial Ownership, Common Stock